Procter & Gamble Company (PG) Valuation

Based on the GoodMoat Investment Framework, the valuation assessment for Procter & Gamble is unfavourable. The primary tool, the DCF-derived GoodMoat Target of $122.70, indicates the stock is trading at a 17% premium to its estimated intrinsic value. This results in a negative margin of safety, which falls into the 'Unfavourable' band (less than 10%) as defined in Section 4. Supporting this view, the forward P/E of 20.4x appears elevated. It is above the sector average for Consumer Defensive stocks and likely at the higher end of its own historical range, especially when contextualized against the company's modest 1.5% YoY revenue growth. While the company exhibits strong quality indicators like a 31.6% ROE and a 4.2% FCF yield, the valuation multiples do not offer a discount for a value investor. The stock is priced for perfection, requiring flawless execution to justify its current premium. For a value investor seeking a margin of safety, the current price does not provide an attractive entry point relative to the estimated fair value. Analysis based on data as of 2024-05-15.